← Back to Search

Treatment for Neonatal Opioid Withdrawal Syndrome (OBOE Trial)

N/A
Recruiting
Research Sponsored by Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 22-24 months of age
Awards & highlights

Summary

This trial will study how prenatal exposure to opioids affects brain development in infants over their first two years of life.

Eligible Conditions
  • Neonatal Opioid Withdrawal Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~22-24 months of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and 22-24 months of age for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
related to behavioral and development: BITSEA
related to behavioral and development: Bayley Scales of Infant Development
related to behavioral and development: Spot Vision Screener
+5 more

Find a Location

Who is running the clinical trial?

Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) ProgramLead Sponsor
2 Previous Clinical Trials
1,495 Total Patients Enrolled
1 Trials studying Neonatal Opioid Withdrawal Syndrome
190 Patients Enrolled for Neonatal Opioid Withdrawal Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,014 Previous Clinical Trials
2,696,534 Total Patients Enrolled
1 Trials studying Neonatal Opioid Withdrawal Syndrome
190 Patients Enrolled for Neonatal Opioid Withdrawal Syndrome
Carla Bann, PhDStudy DirectorRTI International
~59 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top